| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acetylation of E2F1 at K125 facilitates cell apoptosis under serum stress
|
Fang, Zejun
|
|
|
52 |
C |
p.
|
article
|
| 2 |
Adenomas from individuals with pathogenic biallelic variants in the MUTYH and NTHL1 genes demonstrate base excision repair tumour mutational signature profiles similar to colorectal cancers, expanding potential diagnostic and variant classification applications
|
Walker, Romy
|
|
|
52 |
C |
p.
|
article
|
| 3 |
AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane
|
Pan, Yinglian
|
|
|
52 |
C |
p.
|
article
|
| 4 |
ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancer
|
Lin, Yang-Hsiang
|
|
|
52 |
C |
p.
|
article
|
| 5 |
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma
|
Li, Bo
|
|
|
52 |
C |
p.
|
article
|
| 6 |
ATM in immunobiology: From lymphocyte development to cancer immunotherapy
|
Lee, Ji-Hoon
|
|
|
52 |
C |
p.
|
article
|
| 7 |
Autophagy activation in response to cigarette smoke: Exploring the disparity in laryngeal cancer incidence and outcomes between sexes in South Korea
|
Kim, Min Ji
|
|
|
52 |
C |
p.
|
article
|
| 8 |
Beyond first-line therapy: efficacy and safety outcomes of continuing immunotherapy in extensive stage small cell lung cancer after PD-L1 inhibitor progression
|
Peng, Jianfeng
|
|
|
52 |
C |
p.
|
article
|
| 9 |
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer
|
Roggero, Carlos M
|
|
|
52 |
C |
p.
|
article
|
| 10 |
Cellular heterogeneity and cytokine signatures in acute myeloid leukemia: A novel prognostic model
|
Cao, Jinxia
|
|
|
52 |
C |
p.
|
article
|
| 11 |
circICMT upregulates and suppresses the malignant behavior of bladder cancer
|
Luo, Xin
|
|
|
52 |
C |
p.
|
article
|
| 12 |
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
|
Ruglioni, Martina
|
|
|
52 |
C |
p.
|
article
|
| 13 |
Clonal hematopoiesis of indeterminate potential is a risk factor of gastric cancer: A Prospective Cohort in UK Biobank study
|
Xi, Zhihui
|
|
|
52 |
C |
p.
|
article
|
| 14 |
Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia
|
Zhou, Qi
|
|
|
52 |
C |
p.
|
article
|
| 15 |
Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancer
|
Dou, Lei
|
|
|
52 |
C |
p.
|
article
|
| 16 |
ConvXGB: A novel deep learning model to predict recurrence risk of early-stage cervical cancer following surgery using multiparametric MRI images
|
Wu, Ji
|
|
|
52 |
C |
p.
|
article
|
| 17 |
Corrigendum to “Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models” [Translational Oncology volume 39 (2024) 101803]
|
Yuan, Yuncang
|
|
|
52 |
C |
p.
|
article
|
| 18 |
Corrigendum to “Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer” [Transl Oncol. 2024 Aug;46:101983.]
|
Duan, Xiaoyang
|
|
|
52 |
C |
p.
|
article
|
| 19 |
Cross-Talk between NOK and EGFR: Juxtamembrane and Kinase domain interactions enhancing STAT3/5 signaling in breast cancer tumorigenesis
|
Wang, Yinyin
|
|
|
52 |
C |
p.
|
article
|
| 20 |
Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy
|
Du, Kun
|
|
|
52 |
C |
p.
|
article
|
| 21 |
Development and validation of a prognostic and drug sensitivity model for gastric cancer utilizing telomere-related genes
|
Li, Xiaoxiao
|
|
|
52 |
C |
p.
|
article
|
| 22 |
Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction
|
Verbeke, Stéphanie
|
|
|
52 |
C |
p.
|
article
|
| 23 |
Early onset pancreatic cancer: A review
|
Luo, Dong
|
|
|
52 |
C |
p.
|
article
|
| 24 |
EMC2 suppresses ferroptosis via regulating TFRC in nasopharyngeal carcinoma
|
Chen, Xianghui
|
|
|
52 |
C |
p.
|
article
|
| 25 |
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection
|
Zhang, Wei
|
|
|
52 |
C |
p.
|
article
|
| 26 |
ENO1 promotes PDAC progression by inhibiting CD8+ T cell infiltration through upregulating PD-L1 expression via HIF-1α signaling
|
Aziguli Tulamaiti,
|
|
|
52 |
C |
p.
|
article
|
| 27 |
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition
|
Melzer, Yasmin F
|
|
|
52 |
C |
p.
|
article
|
| 28 |
Exogenous dihomo-γ-linolenic acid triggers ferroptosis via ACSL4-mediated lipid metabolic reprogramming in acute myeloid leukemia cells
|
Jiang, Xiandong
|
|
|
52 |
C |
p.
|
article
|
| 29 |
Exploration of the mechanism of 5-Methylcytosine promoting the progression of hepatocellular carcinoma
|
Zhang, Qiyao
|
|
|
52 |
C |
p.
|
article
|
| 30 |
Habitat radiomics based on CT images to predict survival and immune status in hepatocellular carcinoma, a multi-cohort validation study
|
Chen, Kun
|
|
|
52 |
C |
p.
|
article
|
| 31 |
Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy
|
Ding, Chen
|
|
|
52 |
C |
p.
|
article
|
| 32 |
3-Hydroxyanthranic acid inhibits growth of oral squamous carcinoma cells through growth arrest and DNA damage inducible alpha
|
Gan, Guifang
|
|
|
52 |
C |
p.
|
article
|
| 33 |
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma
|
An, Wei
|
|
|
52 |
C |
p.
|
article
|
| 34 |
Identification and validation of a prognostic risk model based on radiosensitivity-related genes in nasopharyngeal carcinoma
|
Li, Yi
|
|
|
52 |
C |
p.
|
article
|
| 35 |
Impact of radiotherapy on secondary lung cancer risk and survival in elderly female breast cancer survivors
|
Lu, Jieming
|
|
|
52 |
C |
p.
|
article
|
| 36 |
Lnc-EST885 promotes hepatocellular carcinoma metastasis through PI3K / AKT pathway by interaction with TRAF4
|
Zhu, Shaoliang
|
|
|
52 |
C |
p.
|
article
|
| 37 |
LPCAT3 regulates the proliferation and metastasis of serous ovarian cancer by modulating arachidonic acid
|
Wen, Fang
|
|
|
52 |
C |
p.
|
article
|
| 38 |
Lysyl oxidase inhibitors in colorectal cancer progression
|
Liu, Muxian
|
|
|
52 |
C |
p.
|
article
|
| 39 |
MAGI2-AS3 hypermethylated in promoter region promotes migration and invasion of head and neck squamous cell carcinoma via miRNA-31-5p/AR axis
|
Yue, Kai
|
|
|
52 |
C |
p.
|
article
|
| 40 |
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy
|
Ni, Gaofeng
|
|
|
52 |
C |
p.
|
article
|
| 41 |
Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia
|
Zhang, Rui
|
|
|
52 |
C |
p.
|
article
|
| 42 |
Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.
|
Mokkapati, Sharada
|
|
|
52 |
C |
p.
|
article
|
| 43 |
MRI-based deep learning and radiomics for predicting the efficacy of PD-1 inhibitor combined with induction chemotherapy in advanced nasopharyngeal carcinoma: A prospective cohort study
|
Wang, Yiru
|
|
|
52 |
C |
p.
|
article
|
| 44 |
MRTX1133 attenuates KRASG12D mutated-colorectal cancer progression through activating ferroptosis activity via METTL14/LINC02159/FOXC2 axis
|
Zou, Junwei
|
|
|
52 |
C |
p.
|
article
|
| 45 |
Multifaceted functions of the Wilms tumor 1 protein: From its expression in various malignancies to targeted therapy
|
Nian, Qing
|
|
|
52 |
C |
p.
|
article
|
| 46 |
PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1α degradation
|
Li, Yaoxu
|
|
|
52 |
C |
p.
|
article
|
| 47 |
PMAIP1-mediated glucose metabolism and its impact on the tumor microenvironment in breast cancer: Integration of multi-omics analysis and experimental validation
|
Zhang, Yidong
|
|
|
52 |
C |
p.
|
article
|
| 48 |
Potentialities and critical issues of liquid biopsy in clinical practice: An umbrella review
|
Veronese, Nicola
|
|
|
52 |
C |
p.
|
article
|
| 49 |
Prognostic implications of immune classification based on PD-L1 expression and tumor-infiltrating lymphocytes in endocervical adenocarcinoma
|
Wei, Li-Jun
|
|
|
52 |
C |
p.
|
article
|
| 50 |
Prognostic prediction for inflammatory breast cancer patients using random survival forest modeling
|
Jia, Yiwei
|
|
|
52 |
C |
p.
|
article
|
| 51 |
Prognostic significance of perioperative circulating CD56bright NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery
|
You, Jeng-Fu
|
|
|
52 |
C |
p.
|
article
|
| 52 |
Response Gene to Complement 32 is associated with poor patient survival and an inflamed tumor-immune microenvironment in clear cell renal cell carcinoma
|
Li, Lingling
|
|
|
52 |
C |
p.
|
article
|
| 53 |
Role of 3-mercaptopyruvate sulfurtransferase in cancer: Molecular mechanisms and therapeutic perspectives
|
Zhang, Ka
|
|
|
52 |
C |
p.
|
article
|
| 54 |
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
|
Briggs, Kimberly J.
|
|
|
52 |
C |
p.
|
article
|
| 55 |
UGCG promotes chemoresistance and breast cancer progression via NF-κB and Wnt/β-catenin pathway activation
|
Long, Li
|
|
|
52 |
C |
p.
|
article
|
| 56 |
Wilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening
|
Götz, Lisa
|
|
|
52 |
C |
p.
|
article
|
Journal description